Results 121 to 130 of about 29,449 (247)

Unraveling Catechol-O-Methyltransferase rs4680 SNP's Role in Patients' Response to Tramadol and Its Adverse Effects: A Pharmacogenetics Insight into Postoperative Pain Management. [PDF]

J Clin Med, 2023
Khan A, Waheed A, Afsar T, Abusharha A, Shafique H, Razak S.   +5 more
europepmc   +1 more source

Estradiol and the Catechol-o-methyltransferase Gene Interact to Predict Working Memory Performance: A Replication and Extension. [PDF]

J Cogn Neurosci, 2023
Louis CC, Jacobs E, D'Esposito M, Moser J.   +3 more
europepmc   +1 more source

The catechol-O-methyltransferase and monoamine oxidase B polymorphisms and levodopa therapy in the Iranian patients with sporadic Parkinson’s disease

, 2012
Anahita Torkaman‐Boutorabi, G. Shahidi S. Choopani, Mohammad Ebrahim Rezvani, Kosar Pourkosary, Majid Golkar, Mohammad‐Reza Zarrindast, Mohammad-Reza Zarrindast   +6 more
openalex   +2 more sources

Catechol-O-Methyltransferase Loss Drives Cell-Specific Nociceptive Signaling via the Enteric Catechol-O-Methyltransferase/microRNA-155/Tumor Necrosis Factor α Axis. [PDF]

Gastroenterology, 2023
Zhou Q, Yang L, Verne ML, Zhang BB, Fields J, Verne GN.   +5 more
europepmc   +1 more source

Áhrif og tengsl catechol-O-methyltransferase (COMT Val158Met) breytileikans á alvarleika ADHD einkenna og meðfylgjandi hegðunarröskun [PDF]

, 2009
Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/OpenAthyglisbrestur og ofvirkni (ADHD) er algeng taugaþroskaröskun sem getur haft víðtæk áhrif á daglegt líf, nám og félagslega aðlögun einstaklinga1.
Freitag, C, Haukur Örvar Pálmason, Hänig, S, Marcus, A, Meyer, J, Moser, D, Schneider, A, Seitz, C, Sigmund, J, Vogler, C   +9 more
core  

Two Faces of Catechol-O-Methyltransferase Inhibitor on One-Carbon Metabolism in Parkinson's Disease: A Meta-Analysis. [PDF]

Nutrients, 2023
Kim JH, Jin S, Eo H, Oh MS, Lim Y.
europepmc   +1 more source

Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders. [PDF]

, 2014
Methylphenidate (MPH) reduces hyperactive-impulsive symptoms common in children with autism spectrum disorders (ASDs), however, response and tolerability varies widely.
Aman, MG, Arnold, LE, Badashova, KK, Chuang, SZ, Davies, M, McCracken, JT, McDougle, CJ, Nurmi, EL, Posey, DJ, Scahill, L, Shah, B, Tierney, E, Vitiello, B, Whelan, F   +13 more
core  

Opicapone Pharmacokinetics and Effects on Catechol- O -Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa. [PDF]

Clin Neuropharmacol, 2023
LeWitt P, Liang GS, Olanow CW, Kieburtz KD, Jimenez R, Olson K, Klepitskaya O, Loewen G.   +7 more
europepmc   +1 more source

New isoflavones, inhibiting catechol-O-methyltransferase, produced by Streptomyces.

, 1975
Hideo Chimura, TSUTOMU SAWA, Yoshiki Kumada, HIROSHI NAGANAWA, MEIKI MATSUZAKI, TOMOHISA TAKITA, MASA HAMADA, TOMIO TAKEUCHI, HAMAO UMEZAWA   +8 more
openalex   +2 more sources

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson's disease: opicapone versus entacapone. [PDF]

J Neural Transm (Vienna), 2023
Leta V, van Wamelen DJ, Aureli F, Metta V, Trivedi D, Cortelli P, Rodriguez-Blazquez C, Rizos A, Ray Chaudhuri K.   +8 more
europepmc   +1 more source